文献速递乳腺MR

Node Reporting and Data System评分在浸润性导管癌与浸润性小叶癌腋窝淋巴结评估中的应用

Node Reporting and Data System Evaluation of Axillary Nodes in Invasive Ductal and Lobular Carcinoma.
PubMed 文献 · Radiology · 2025-01-01

本回顾性研究纳入2017年1月至2018年12月病理确诊的1602例女性(1627个乳腺癌),用Node-RADS评分预测腋窝淋巴结转移。Node-RADS评分≥3分时,浸润性导管癌敏感度71.1%、特异度86.5%,浸润性小叶癌敏感度52.5%、特异度85.1%;小叶癌敏感度显著较低(P = .02),AUC分别为0.83和0.74(P = .08)。

要点

  • Node-RADS评分≥3分为两种组织学类型预测腋窝淋巴结转移的最佳约登指数截断值。
  • 浸润性小叶癌的Node-RADS敏感度显著低于浸润性导管癌(P = .02)。
  • Node-RADS评分是多变量分析中腋窝淋巴结转移的独立预测因子(OR 3.1,P < .001)。

核心结论

  • Node-RADS评分在浸润性导管癌与浸润性小叶癌腋窝淋巴结评估中AUC表现相当,但浸润性小叶癌的敏感度较低。

研究设计与样本

  • 回顾性研究,纳入2017年1月至2018年12月期间病理确诊为浸润性导管癌或浸润性小叶癌并接受术前乳腺MRI的连续女性患者,共1602例(平均年龄50.6岁 ± 9.8 [SD]),含25例双侧乳腺癌,共1627个乳腺癌(浸润性导管癌1486个,浸润性小叶癌141个)。

诊断标准与关键数值

  • Node-RADS评分结合淋巴结大小与形态标准,最终评分为1分(极低怀疑)至5分(极高怀疑);评分≥3分在两种组织学类型中均获得最高约登指数。浸润性导管癌:敏感度71.1%(268/377)、特异度86.5%(959/1109);浸润性小叶癌:敏感度52.5%(21/40)、特异度85.1%(86/101)。AUC浸润性导管癌0.83 vs 浸润性小叶癌0.74(P = .08)。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background Although the Node Reporting and Data System (Node-RADS) offers a standardized method for assessing lymph node metastasis, its performance may vary according to the histologic type of breast cancer. Purpose To evaluate the applicability of the Node-RADS score in assessing axillary lymph node involvement in patients with invasive ductal carcinoma (IDC) or invasive lobular carcinoma (ILC). Materials and Methods In this retrospective study, data from consecutive women with pathologically confirmed IDC or ILC who underwent preoperative breast MRI between January 2017 and December 2018 were analyzed. Axillary nodal status was assessed using Node-RADS, in which nodal size and configuration criteria are combined into a final assessment score ranging from 1 (very low suspicion) to 5 (very high suspicion). The performance of the Node-RADS score for predicting axillary lymph node metastasis was compared between the two histologic types using the χ2 test. Results A total of 1602 women (mean age, 50.6 years ± 9.8 [SD]), including 25 with bilateral cancers, were included, yielding 1627 breast cancers. Among these cancers, 1486 were IDC and 141 were ILC. The frequency of lymph node metastasis was 25% (377 of 1486) for IDC and 28% (40 of 141) for ILC (P = .44). A Node-RADS score of 3 or greater yielded the highest Youden index for predicting axillary lymph node metastasis for both histologic types. At this cutoff, the sensitivity and specificity were 71.1% (268 of 377) and 86.5% (959 of 1109) for IDC and 52.5% (21 of 40) and 85.1% (86 of 101) for ILC, respectively. Although there was no evidence of a difference in specificity between the histologic types, sensitivity was significantly lower for ILC (P = .02). The area under the receiver operating characteristic curve (AUC) was 0.83 for IDC and 0.74 for ILC (P = .08). Multivariable logistic regression analyses confirmed Node-RADS score as an independent predictor of axillary lymph node metastasis (odds ratio, 3.1; P < .001). Conclusion The Node-RADS score demonstrated comparable performance in terms of AUC in axillary nodal evaluation for IDC and ILC but lower sensitivity for ILC. © RSNA, 2025 Supplemental material is available for this article. See also the editorial by Freitas in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Kim HJ, Chae EY, Eom HJ, et al. Node Reporting and Data System Evaluation of Axillary Nodes in Invasive Ductal and Lobular Carcinoma. Radiology. 2025. PMID: 40891975. doi:10.1148/radiol.243823

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。